Search Cancer Clinical Trials
Home > Cancer (Oncology) > Research and Clinical Trials > Clinical Trials > Search Cancer Clinical Trials
Print

Research and Clinical Trials

Search Cancer Clinical Trials

Clinical Trials

New Search
Title Principal Investigator Post Date
International Multi-center Phase 2 Study to Evaluate the Safety and Efficacy of Sequential Melphalan Hydrochloride for Injection for Use With the Hepatic Delivery System Treatment Followed by Sorafenib in Patients With Unresectable Hepatocellular Carc Milan Kinkhabwala, MD   
A Clinical Study in Three-arm of Lurbinectedin (PM01183) Alone or in Combination With Gemcitabine and a Control Arm With Docetaxel as Second Line Treatment in Non-Small Cell Lung Cancer (NSCLC) Patients Haiying Cheng, MD   
A Clinical Study Using MEDI-551 in Adult Subjects With Relapsed or Refractory Advanced B-Cell Malignancies Noah Kornblum, MD   
A Dose Escalation Study in Adult Patients With Advanced Solid Malignancies Sanjay Goel, MD   
A Global Study to Assess the Effects of MEDI4736 Following Concurrent Chemoradiation in Patients With Stage III Unresectable Non-Small Cell Lung Cancer (PACIFIC) Missak Haigentz, MD   
A Global Study to Assess the Effects of MEDI4736 in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ATLANTIC) Missak Haigentz, MD   
A Global Study to Assess the Effects of MEDI4736, Given as Monotherapy or in Combination With Tremelimumab Determined by PD-L1 Expression Versus Standard of Care in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer (ARCTIC) Missak Haigentz, MD   
A Multi-center, AZD9291 Expanded Access Program for the Treatment of Patients With Advanced/Metastatic EGFR T790M Mutation-positive Non-small Cell Lung Cancer (NSCLC) Who Have Received Prior EGFR TKI Therapy Haiying Cheng, MD   
A Multicenter Open-Label Phase 2a Study of Ibrutinib With or Without Cytarabine in Subjects With Acute Myeloid Leukemia Amit Verma, MD   
A Phase 1, Open-label, Dose-escalation Study of SEA-CD40 in Adult Patients With Advanced Malignancies Sanjay Goel, MD   
A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies Sanjay Goel, MD   
A Phase 1/2 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MEDI4736 in Subjects With Advanced Solid Tumors Sanjay Goel, MD   
A Phase 2 of Entospletinib in Subjects With Relapsed or Refractory Hematologic Malignancies Ramakrishna Battini, MD   
A Phase 2 Study of Fosbretabulin in Subjects With Gastrointestinal Neuroendocrine Tumors (GI-NET) and With Elevated Biomarkers Steven Libutti, MD    
A Phase 2 Study of MM-121 in Combination With Docetaxel or Pemetrexed Versus Docetaxel or Pemetrexed Alone in Patients With Heregulin Positive, Locally Advanced or Metastatic Non-Small Cell Lung Cancer Haiying Cheng, MD   
A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study of Azacitidine With or Without Birinapant With a Single Arm Open-Label Run-In Phase in Subjects With Higher Risk Myelodysplastic Syndrome or Chronic Myelomonocytic Leukemia Amit Verma, MD   
A Phase I/II Evaluation of ADXS11-001, Mitomycin, 5-fluorouracil (5-FU) and IMRT for Anal Cancer (276) Lakshmi Rajdev, MD    
A Phase Ib Study of MEK162 Plus BYL719 in Adult Patients With Selected Advanced Solid Tumors Kira Gritsman, MD   
A Phase II Study of Sodium Cridanimod in Conjunction With Progestin Therapy in Patients With Progesterone Receptor Negative Recurrent or Persistent Endometrial Carcinoma Nicole Nevadusky, MD    
A Phase II, Randomized, Double-blind, Placebo-controlled Study to Examine the Effects of DAS181 in Immunocompromised Subjects With Lower Respiratory Tract Parainfluenza Infection on Supplemental Oxygen (DAS181-2-05) Ira Braunschweig, MD   
A Phase III Randomized Trial Comparing Androgen Deprivation Therapy + TAK-700 With Androgen Deprivation Therapy + Bicalutamide in Patients With Newly Diagnosed Metastatic Sensitive Prostate Cancer Benjamin Gartrell, MD   
A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi (BELLE-3) Jesus Anampa Mesias, MD    
A pilot randomized trial comparing arm circumference and bioimpedence measurement for early detection and treatment of lymphedema in patients undergoing axillary lymph node dissection or sentinel node biopsy Lisa Wiechmann, MD   
A PROspective, Observational, US-based Study Assessing Outcomes, Adverse Events, Treatment Patterns, and Quality of Life in Patients Diagnosed With Mycosis Fungoides Cutaneous T-cell Lymphoma and Treated With Valchlor® Holly Kanavy, DO   
A Randomized Phase IIa Efficacy and Safety Study of Radium-223 Dichloride With Abiraterone Acetate or Enzalutamide in Metastatic Castration-resistant Prostate Cancer (CRPC) Benjamin Gartrell, MD    
A Study Comparing Kadcyla Plus Perjeta Treatment to Chemotherapy Combined With Herceptin Plus Perjeta in Patients With HER2-Positive Breast Cancer Jesus Anampa Mesias, MD    
A Study of ARN-509 in Men With Non-Metastatic Castration-Resistant Prostate Cancer (SPARTAN) Benjamin Gartrell, MD    
A Study of Atezolizumab (MPDL3280A) in Combination With Nab-Paclitaxel Compared With Placebo With Nab-Paclitaxel for Patients With Previously Untreated Metastatic Triple Negative Breast Cancer (IMpassion130) Joseph Sparano, MD   
A Study of AZD1775 + Chemotherapy Versus Chemotherapy in Patients to Treat Ovarian, Fallopian Tube, Peritoneal Cancer Gloria Huang, MD   
A Study of Cobimetinib in Combination With Paclitaxel as First-line Treatment for Patients With Metastatic Triple-negative Breast Cancer Joseph Sparano, MD   
A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL Murali Janakiram, MD   
A Study of LY3039478 in Participants With Advanced Cancer Sanjay Goel, MD   
A Study of MEK162 vs. Physician's Choice Chemotherapy in Patients With Low-grade Serous Ovarian, Fallopian Tube or Peritoneal Cancer Gloria Huang, MD   
A Study of Oral Ixazomib Citrate (MLN9708) Maintenance Therapy in Patients With Multiple Myeloma Following Autologous Stem Cell Transplant Ramakrishna Battini, MD   
A Study of Ruxolitinib in Combination With Capecitabine in Subjects With Advanced or Metastatic HER2-negative Breast Cancer Della Makower, MD    
A Study of the Safety and Efficacy of CMX001 for the Prevention of Cytomegalovirus (CMV) Infection in CMV-seropositive (R+) Hematopoietic Stem Cell Transplant Recipients Olga Derman, MD    
A Study to Evaluate Characteristics Predictive of a Positive Imaging Study for Distant Metastases in Patients With Castration-Resistant Prostate Cancer (PREDICT) Benjamin Gartrell, MD    
A Study to Evaluate Genetic Predictors of Aromatase Inhibitor Musculoskeletal Symptoms (AIMSS) Christine Pellegrino, MD    
A Study Using MABp1 To Increase Overall Survival In Patients With Colorectal Cancer And Weight Loss Sanjay Goel, MD   
Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery Madhur Garg, MD   
Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients (ATLAS) Benjamin Gartrell, MD   
Aflibercept and FOLFOX6 Treatment for Previously Untreated Stage IV Colorectal Cancer Sanjay Goel, MD   
Alisertib, Bortezomib, and Rituximab in Treating Patients With Relapsed or Refractory Mantle Cell Lymphoma or B-cell Low Grade Non-Hodgkin Lymphoma Noah Kornblum, MD   
An Efficacy and Safety Study of JNJ56021927 in Participants With Chemotherapy-naive Metastatic Castration-resistant Prostate Cancer (mCRPC) Benjamin Gartrell, MD    
An Observational Study in Differentiated Thyroid Cancer Which is Radioactive Iodine (RAI) Refractory to Assess the Use of Multikinase Inhibitors (RIFTOS MKI) Missak Haigentz, MD   
An Open Label Multi-center Extension Study to Evaluate Long-term Safety/ Tolerability of Dovitinib in Patients With Solid Tumors Who Continue to Receive Treatment With Dovitinib (TKI258) in Novartis-sponsored Single Agent Dovitinib Studies Sanjay Goel, MD    
Anal HPV Tests in Screening for Cell Changes in the Anus in Patients With HIV Rebecca Levine, MD   
Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma Jerome Graber, MD   
Avelumab in Metastatic or Locally Advanced Solid Tumors Sanjay Goel, MD   
Belinostat for Solid Tumors and Lymphomas in Patients With Varying Degrees of Hepatic Dysfunction Sanjay Goel, MD   
Bevacizumab With or Without Trebananib in Treating Patients With Recurrent Brain Tumors Mary Welch, MD    
Bortezomib or Carfilzomib With Lenalidomide and Dexamethasone in Treating Patients With Newly Diagnosed Multiple Myeloma Fernando Camacho, MD   
Brentuximab Vedotin and Combination Chemotherapy in Treating Patients With Stage II-IV HIV-Associated Hodgkin Lymphoma Murali Janakiram, MD    
Cabozantinib-S-Malate in Treating Patients With Advanced Solid Tumors and Human Immunodeficiency Virus Jennifer Chuy, MD   
Cabozantinib-s-malate or Sunitinib Malate in Treating Patients With Previously Untreated Locally Advanced or Metastatic Kidney Cancer Benjamin Gartrell, MD   
Carrageenan-Containing Gel in Reducing the Rate of HPV Infection in Healthy Participants Mark Einstein, MD   
Chemoradiation Therapy and Ipilimumab in Treating Patients With Locally Advanced Cervical Cancer Gary Goldberg, MD   
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy Gary Goldberg, MD   
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer Eleni Andreopoulou, MD   
CIRSE Registry for SIR-Spheres Therapy (CIRT) Madhur Garg, MD   
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer Gary Goldberg, MD   
Collecting and Studying Tissue Samples From Patients With HIV-Associated Malignancies Missak Haigentz, MD    
Combination Chemotherapy With or Without Blinatumomab in Treating Patients With Newly Diagnosed BCR-ABL-Negative B Lineage Acute Lymphoblastic Leukemia Olga Derman, MD   
Combination Chemotherapy, Gemcitabine Hydrochloride, and Radiation Therapy Before Surgery in Treating Patients With Borderline Resectable Pancreatic Cancer Jennifer Chuy, MD   
Combination Study of Deferasirox and Erythropoietin in Patients With Low- and Int-1-risk Myelodysplastic Syndrome. Olga Derman, MD   
Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery Merieme Klobocista, MD   
Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry Amit Verma, MD   
Continuous Activity Monitoring During Fractionated Radiotherapy in Patients With Head and Neck, Lung, or Gastrointestinal Cancer Nitin Ohri   
Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery and ALK Fusion Mutations (An ALCHEMIST Treatment Trial) Steven Keller, MD   
Cyclophosphamide With or Without Veliparib in Patients With Locally Advanced or Metastatic Breast Cancer Eleni Andreopoulou, MD    
Dasatinib in Treating Patients With Locally Advanced or Metastatic Mucosal Melanoma, Acral Melanoma, or Vulvovaginal Melanoma That Cannot Be Removed By Surgery Joseph Sparano, MD   
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Nicole Nevadunsky, MD   
Dose-Finding, Safety and Efficacy Study of RX-0201 Plus Everolimus in Metastatic Renal Cell Cancer Sanjay Goel, MD   
Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Joseph Sparano, MD   
ECHELON-2: A Comparison of Brentuximab Vedotin and CHP With Standard-of-care CHOP in the Treatment of Patients With CD30-positive Mature T-cell Lymphomas Ramakrishna Battini, MD   
Efficacy and Safety of Aldoxorubicin Compared to Topotecan in Subjects With Metastatic Small Cell Lung Cancer Rasim Gucalp, MD   
Efficacy and Safety of Idelalisib (GS-1101) in Combination With Rituximab for Previously Treated Indolent Non-Hodgkin Lymphomas (Yosemite) Ramakrishna Battini, MD   
Enzalutamide With or Without Abiraterone and Prednisone in Treating Patients With Castration-Resistant Metastatic Prostate Cancer Benjamin Gartrell, MD    
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer Bilal Piperdi, MD   
Erlotinib Hydrochloride Before Surgery in Treating Patients With Stage III Non-Small Cell Lung Cancer (EVENT) Haiying Cheng, MD   
Erlotinib Hydrochloride in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Completely Removed by Surgery (An ALCHEMIST Treatment Trial) Steven Keller, MD   
Evaluating a Novel Onco-genetic BRCA Testing Counselling Model Among Patients With Ovarian Cancer (ENGAGE) Gloria Huang, MD   
Evaluation of Carboplatin/Paclitaxel With and Without Trastuzumab (Herceptin) in Uterine Serous Cancer Nicole Nevadunsky, MD   
Everolimus in Patients With Pancreatic Neuroendocrine Tumors Metastatic to the Liver Previously Treated With Surgery Steven Libutti, MD    
Exemestane With or Without Entinostat in Treating Postmenopausal Patients With Recurrent Hormone Receptor-Positive Breast Cancer That Is Locally Advanced or Metastatic Christine Pellegrino, MD    
Exploratory Study Of The ERCC-1 Gene Expression In Colorectal Cancer Cell Lines And In Patients With Colorectal Cancer Sanjay Goel, MD   
Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery Christine Pellegrino, MD   
Gemcitabine Hydrochloride, Docetaxel, and Radiation Therapy in Treating Patients With Uterine Sarcoma That Has Been Removed By Surgery Merieme Klobocista, MD   
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial) Steven Keller, MD   
Image-Guided Radiosurgery or Stereotactic Body Radiation Therapy in Treating Patients With Localized Spine Metastasis Madhur Garg, MD   
Immune Monitoring Protocol in Men With Prostate Cancer Enrolled in a Clinical Trial of Sipuleucel-T (PRIME) Sanjay Goel, MD   
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia Amit Verma, MD   
Inhaled Azacitidine in Patients With Advanced Non-small Cell Lung Cancer Roman Perez-Soler, MD   
Ipilimumab With or Without Bevacizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Removed by Surgery Stuart Packer, MD   
Lenalidomide in Treating Older Patients With Acute Myeloid Leukemia Who Have Undergone Stem Cell Transplant Ira Braunschweig, MD    
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma Ramakrishna Battini, MD   
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia Amit Verma, MD   
Lung Cancer Information Study (LCIS-R01) Richard Gralla, MD   
Lung-MAP: S1400 Biomarker-Targeted Second-Line Therapy in Treating Patients With Recurrent Stage IIIB-IV Squamous Cell Lung Cancer Haiying Cheng, MD   
LUX-Head&Neck 2: A Phase III Trial of Afatinib (BIBW 2992) Versus Placebo for the Treatment of Head and Neck Squamous Cell Cancer After Treatment With Chemo-radiotherapy Missak Haigentz, MD   
M402 in Combination With Nab-Paclitaxel and Gemcitabine in Pancreatic Cancer Jennifer Chuy, MD   
MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients (HERMIONE) Joseph Sparano, MD   
Molecular and Genomic Profiling of Head and Neck Tumors Richard Smith, MD   
MRI and Gene Expression in Diagnosing Patients With Ductal Breast Cancer In Situ Beatriu Reig, MD   
MRI and Mammography Before Surgery in Patients With Stage I-II Breast Cancer Beatriu Reig, MD    
Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors Sanjay Goel, MD   
Nivolumab and Ipilimumab in Treating Patients With Advanced HIV Associated Solid Tumors Lakshmi Rajdev, MD   
Observational Cohort Study of Patients With Castration-Resistant Prostate Cancer (CRPC) (TRUMPET) Benjamin Gartrell, MD    
Olaparib as Adjuvant Treatment in Patients With Germline BRCA Mutated High Risk HER2 Negative Primary Breast Cancer (OlympiA) Jesus Anampa Mesias, MD    
Oxaliplatin, Leucovorin Calcium, and Fluorouracil With or Without Celecoxib in Treating Patients With Stage III Colon Cancer Previously Treated With Surgery Sanjay Goel, MD   
Paclitaxel and Intraperitoneal Carboplatin Followed by Radiation Therapy in Treating Patients With Stage IIIC-IV Uterine Cancer Merieme Klobocista, MD   
Palliative Care in Improving Quality of Life in Patients With High Risk Primary or Recurrent Gynecologic Malignancies Nicole Nevadunsky, MD   
Pase II Study of MEDI4736, Tremelimumab, and MEDI4736 in Combination w/ Tremelimumab Squamous Cell Carcinoma of the Head and Neck Missak Haigentz, MD   
Pazopanib Hydrochloride in Treating Patients With Metastatic Kidney Cancer Who Have No Evidence of Disease After Surgery Benjamin Gartrell, MD    
Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors Steven Libutti, MD    
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-Small Cell Lung Cancer (PAINT) Nitin Ohri, MD   
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer (PAINT) Nitin Ohri, MD   
Pharmacokinetic and Safety Study of Lower Doses of Ceritinib Taken With a Low-fat Meal Versus 750 mg of Ceritinib in the Fasted State in Adult Patients With (ALK-positive) Metastatic Non-small Cell Lung Cancer (NSCLC) Sanjay Goel, MD   
Phase 1/2, First-in-Human, Dose-Escalation Study of X-396 in Patients With Advanced Solid Tumors and Expansion Phase in Patients With ALK-positive Non-Small Cell Lung Cancer Haiying Cheng, MD   
Phase 2 Study of MGCD265 in Patients With Non-Small Cell Lung Cancer With Activating Genetic Alterations in MET Balazs Halmos, MD   
Phase 2a Study of BAX69 and 5-FU/Leucovorin or Panitumumab Versus Standard of Care in Subjects With Metastatic Colorectal Cancer Sanjay Goel, MD   
Phase I/II Trial of Ruxolitinib in Combination With Trastuzumab in Metastatic HER2 Positive Breast Cancer Della Makower, MD    
Phase II Randomized Trial Comparing GA101 and Rituximab in Untreated Low Tumor Burden Indolent Non-Hodgkin's Lymphoma (PrE0401) Noah Kornblum, MD    
Phase II Study of Dose-Adjusted EPOCH-Rituximab in Adults With Untreated Burkitt Lymphoma and c-MYC+ Diffuse Large B-Cell Lymphoma Ramakrishna Battini, MD   
Phase II Study of Lenalidomide and Eltrombopag in Patients with Symptomatic Anemia in Low or Intermediate I Myelodysplastic Syndrome Amit Verma, MD   
Phase II Study of MEDI4736 Monotherapy in Treatment of Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck Missak Haigentz, MD   
Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma (PrE0204) Andreas Kaubisch, MD   
Phase III Study of DCVAC Added to Standard Chemotherapy for Men With Metastatic Castration Resistant Prostate Cancer (VIABLE) Benjamin Gartrell, MD    
Prophylactic Antibiotic Regimens in Tumor Surgery (PARITY) David Geller, MD   
PROSPECT: Chemotherapy Alone or Chemotherapy Plus Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer Undergoing Surgery Rebecca Levine, MD    
Protocol for a Research Sample Repository for Allogeneic Hematopoietic Stem Cell Transplantation Ira Braunschweig, MD    
Radiation Therapy Sandwiched Between Paclitaxel and Carboplatin in Patients With High-risk Endometrial Cancer Dennis Kuo, MD   
Radiation Therapy With or Without Chemotherapy in Patients With Stage I or Stage II Cervical Cancer Who Previously Underwent Surgery Gary Goldberg, MD   
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma Jerome Graber, MD   
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer Merieme Klobocista, MD   
Radiation Therapy, Paclitaxel, and Carboplatin With or Without Trastuzumab in Treating Patients With Esophageal Cancer Lakshmi Rajdev, MD   
Rituximab and Combination Chemotherapy With or Without Lenalidomide in Treating Patients With Newly Diagnosed Stage II-IV Diffuse Large B Cell Lymphoma Ramakrishna Battini, MD   
Rituximab, Bendamustine Hydrochloride, and Bortezomib Followed by Rituximab and Lenalidomide in Treating Older Patients With Previously Untreated Mantle Cell Lymphoma Ramakrishna Battini, MD   
Rollover for Study OX4218s, A P2 Study to Investigate Safety and Activity of Fosbretabulin Tromethamine in the Treatment of Well-Differentiated, Low-to-Intermediate-Grade Unresectable, Recurrent or Metastatic GI-NET With Elevated Biomarkers Steven Libutti, MD    
Ruxolitinib in Combination With Pemetrexed/Cisplatin in Non Small Cell Lung Cancer Missak Haigentz, MD   
S1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast Cancer (e3) Della Makower, MD    
Safety and Efficacy of Nab®-PACLITAXEL (ABRAXANE®) in Combination With Carboplatin as First Line Treatment in Elderly Subjects With Advanced Non-Small Cell Lung Cancer (NSCLC): A Phase IV, Randomized, Open-Label, Multicenter Study (ABOUND.70+) Haiying Cheng, MD   
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma (OPTIMISMM) Ramakrishna Battini, MD   
Safety and Efficacy Study of Abraxane as Maintenance Treatment After Abraxane Plus Carboplatin in 1st Line Stage IIIB / IV Squamous Cell Non-small Cell Lung Cancer (aboundsqm) Haiying Cheng, MD   
Safety Study of ALRN-6924 in Patients With Advanced Solid Tumors Sanjay Goel, MD   
Safety Study of Intratumoral Injection of Clostridium Novyi-NT Spores to Treat Patients With Solid Tumors That Have Not Responded to Standard Therapies Sanjay Goel, MD    
Single Arm Study Treating Patients of Peritoneal Surface Malignancy (Colorectal, Appendical, Pseudomyxoma, Gastric) With Cytoreductive Surgery and Hyperthermic Intraperitoneal Mitomycin-C Timothy Kennedy, MD   
Sorafenib Tosylate With or Without Stereotactic Body Radiation Therapy in Treating Patients With Liver Cancer Nitin Ohri, MD   
Standard or Comprehensive Radiation Therapy in Treating Patients With Early-Stage Breast Cancer Previously Treated With Chemotherapy and Surgery Jana Fox, MD   
Study Of Pf 04449913 In Combination With Azacitidine In Patients With Previously Untreated Intermediate 2 Or High Risk Myelodysplastic Syndrome, Acute Myeloid Leukemia With 20 30% Blasts And Multi Lineage Dysplasia, Or Chronic Myelomonocytic Leukemia Amit Verma, MD   
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer Sanjay Goel, MD   
Study of Ruxolitinib in Pancreatic Cancer Patients (Janus 1) Jennifer Chuy, MD   
Study to Evaluate Activity of 2 Dose Levels of Imetelstat in Participants With Intermediate-2 or High-Risk Myelofibrosis (MF) Previously Treated With Janus Kinase (JAK) Inhibitor Swati Goel, MD   
Temozolomide With or Without Capecitabine in Treating Patients With Advanced Pancreatic Neuroendocrine Tumors Steven Libutti, MD    
The Chimerix CMX001 Registry Olga Derman, MD   
Three Different Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide Nitin Ohri, MD   
TIGER-1: Safety and Efficacy Study of Rociletinib (CO-1686) or Erlotinib in Patients With EGFR Mutant NSCLC Who Have Not Had Any Previous EGFR Directed Therapy Haiying Cheng, MD    
TIGER-2: A Phase 2, Open-label, Multicenter, Safety and Efficacy Study of Oral CO-1686 as 2nd Line EGFR-directed TKI in Patients With Mutant EGFR Non-small Cell Lung Cancer (NSCLC) Haiying Cheng, MD   
Topical or Ablative Treatment in Preventing Anal Cancer in Patients With HIV and Anal High-Grade Squamous Intraepithelial Lesions Rebecca Levine, MD   
Tracking & Feedback Registry to Reduce Breast Cancer Treatment Disparities Jana Fox, MD    
Transoral Surgery Followed By Low-Dose or Standard-Dose Radiation Therapy With or Without Chemotherapy in Treating Patients With HPV Positive Stage III-IVA Oropharyngeal Cancer Missak Haigentz, MD   
Triciribine Phosphate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide in Treating Patients With Stage IIB-IV Breast Cancer Joseph Sparano, MD   
Veliparib, Paclitaxel, and Carboplatin in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery and Liver or Kidney Dysfunction Sanjay Goel, MD   
Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell Lymphomas Murali Janakiram, MD   
Vorinostat in Combination With Paclitaxel and Carboplatin in Treating Patients With Metastatic or Recurrent Solid Tumors and HIV Infection Missak Haigentz, MD   
Voxel Based Diffusion Tensor Imaging in Predicting Response in Patients With Brain Metastases Undergoing Whole Brain Radiation Therapy or Stereotactic Radiosurgery Madhur Garg, MD   
Whole-Brain Radiation Therapy With or Without Lapatinib Ditosylate in Treating Patients With Brain Metastasis From HER2-Positive Breast Cancer Mary Welch, MD